News 2019

« BACK

Pharmacology



Results 41 - 60 of 396.


Health - Pharmacology - 11.11.2019
Pioneering new ‘smart needle' could revolutionise cancer diagnosis
Pioneering new ‘smart needle’ could revolutionise cancer diagnosis
Scientists have developed a pioneering new technique that can detect and diagnose one of the most common types of cancer within seconds - using light. A multidisciplinary team of experts has developed a ground-breaking ‘smart needle' probe that uses light to pinpoint cancerous tissues or cells almost instantaneously.

Health - Pharmacology - 11.11.2019
Retinal imaging technology for early detection of Alzheimer’s disease
Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage to the brain from Alzheimer's disease occurs years before patients exhibit symptoms. Attempted therapies have been unsuccessful largely because there is no measurable indicator - or biomarker - for Alzheimer's disease before it is already symptomatic and advanced. The eye's retina is considered the developmental extension of the brain and can be accessed non-invasively.

Health - Pharmacology - 08.11.2019
UCL hosts minister as part of Tomorrow’s Engineers Week
Universities Minister Chris Skidmore MP visited the UCL Institute of Healthcare Engineering (IHE) Autumn Research Symposium today as part of Tomorrow's Engineers Week. Mr Skidmore met Professor Becky Shipley, Director of the IHE, who with her team demonstrated the REANIMATE project (REAlistic Numerical Image-based Modelling of biological Tissue substratEs), which is a virtual modelling technique that creates highly detailed 3D models of individual cancerous tumours and simulates the delivery of drugs into them.

Pharmacology - Health - 08.11.2019
Immersion in virtual reality scenes of the Arctic helps to ease people's pain
Immersion in virtual reality scenes of the Arctic helps to ease people’s pain
Watching immersive 3D videos of icy Arctic scenes helps to relieve burning pain and could hold hope for treating chronic pain, a study has found. Scientists from Imperial College London have found that using virtual reality headsets could combat increased sensitivity to pain, by immersing people in scenes of icebergs, frigid oceans and sprawling icescapes.

Health - Pharmacology - 07.11.2019
Potential new target for treatment of inflammatory disease
Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease. The research, led by scientists at the University of Birmingham's Institute of Inflammation and Ageing , Institute of Cardiovascular Sciences, and Institute of Metabolism and Systems Research, publishes today in Cell Metabolism.

Health - Pharmacology - 07.11.2019
Simple blood test could better predict both kidney disease and cardiovascular risk
Researchers have found a better way to test for kidney disease using a simple blood test that is affordable and although it is available in NHS laboratories is not yet widely used. In a study, published today and led by the University of Glasgow, researchers have highlighted that a simple blood test - which could easily be adopted routinely in the NHS - is a better way of measuring both kidney and cardiovascular disease risk, as it offers a more precise diagnosis and could lead to better patient outcomes.

Health - Pharmacology - 07.11.2019
Flu shot can provide effective immunity for people living with HIV
People who are being treated for HIV can gain effective protection against seasonal flu with the influenza (flu) vaccine, new findings confirm. Since people living with HIV can have an impaired immune system and may be at higher risk of serious illness from flu, they are recommended to get the seasonal influenza vaccine every year.

Health - Pharmacology - 06.11.2019
"Super-grafts" that could treat diabetes
By successfully strengthening pancreatic islets before transplantation, researchers at UNIGE and HUG are hoping for a significant improvement in the success of cell transplants in patients with severe diabetes. To save patients with a severe form of type 1 diabetes (characterized by the absence of functional insulin-producing cells), pancreatic cell transplantation is sometimes the last resort.

Pharmacology - Philosophy - 06.11.2019
In Hunting for Cures, Ethics Can Strengthen Clinical Trials
Clinical trials provide the cornerstone for evaluating the safety and efficacy of new drugs and therapies to treat disease. While trials are designed to follow established ethical and regulatory requirements, Alex John London , the Clara L. West Professor of Ethics and Philosophy at Carnegie Mellon University, said he believes there is room for improvement.

Pharmacology - Health - 05.11.2019
Q&A: A drug-free option for treating ADHD in children
Deciding how to treat attention deficit hyperactivity disorder in children can be a difficult decision for parents. Stimulants, such as Adderall and Ritalin, are the most commonly prescribed ADHD treatments — and are considered to be the most effective. But in April, the FDA approved the first device-based, non-drug therapy to treat ADHD in children.

Pharmacology - Life Sciences - 04.11.2019
From cone snail venom to pain relief
From cone snail venom to pain relief
Conotoxins are bioactive peptides found in the venom that marine cone snails produce for prey capture and defense. They are used as pharmacological tools to study pain signalling and have the potential to become a new class of analgesics. To date, more than 10,000 conotoxin sequences have been discovered.

Health - Pharmacology - 01.11.2019
New Glasgow Cancer Tests for research and clinical trials
The Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground-breaking new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered. The Glasgow Cancer Tests are a suite of affordable solid tumour and blood cancer tests, developed specifically to enable patients to benefit from real-world precision medicine-based cancer treatments.

Pharmacology - Health - 01.11.2019
New direction for treatment of aggressive type of breast cancer
Researchers identify path to improve HER2+ breast cancer susceptibility to approved therapies Approximately 15 to 20% of breast cancers are caused by changes in a gene known as HER2, which cause the protein produced by the gene to become constantly active, leading to uncontrolled cell growth. Cancers with these genetic changes are called "HER2-positive" or "HER2+" breast cancers.

Pharmacology - Health - 31.10.2019
Checkpoint inhibitor prolongs survival in pa
The checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a new global study led by Yale Cancer Center (YCC). The data was published today in the journal The Lancet. The findings of the phase 3 study show that, compared to the standard therapy, overall survival was significantly improved for participants with previously untreated recurrent or metastatic head and neck cancers.

Health - Pharmacology - 31.10.2019
Measles causes 'immune amnesia' leaving us vulnerable to other diseases
Measles causes ’immune amnesia’ leaving us vulnerable to other diseases
Scientists have shown how measles causes long-term damage to the immune system, leaving people vulnerable to other infections. The international team, which includes the Wellcome Sanger Institute, the University of Amsterdam and Imperial College London, revealed that the measles virus deletes part of the immune system's memory, removing previously existing immunity to other infections, in both humans and ferrets.

Pharmacology - 31.10.2019
Many take anticoagulants and OTC supplements, which poses risk
FINDINGS Nearly 98% percent of people prescribed direct-acting oral anticoagulants such as apixaban also used over-the-counter products. Of those, 33% took at least one such product that, in combination with the anticoagulants, could cause dangerous internal bleeding. People taking these medications largely lacked knowledge of some potentially serious interactions.

Health - Pharmacology - 31.10.2019
Removing liver tumors safely, noninvasively and efficiently
Removing liver tumors safely, noninvasively and efficiently
Many liver tumors have long been difficult or impossible to remove. Since 2015, however, it has been possible to treat these tumors by combining noninvasive surgical techniques, radiological imaging and a navigation system. For the first time, a new study by University of Bern and Inselspital, Berne University Hospital has impressively demonstrated the success of this technique.

Pharmacology - Health - 31.10.2019
Checkpoint inhibitor prolongs survival with certain head and neck cancers
The checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a new global study led by Yale Cancer Center (YCC). The data was published today in the journal The Lancet. The findings of the phase 3 study show that, compared to the standard therapy, overall survival was significantly improved for participants with previously untreated recurrent or metastatic head and neck cancers.

Life Sciences - Pharmacology - 29.10.2019
Scientists invent animal-free testing of lethal neurotoxins
Scientists invent animal-free testing of lethal neurotoxins
Animal testing will no longer be required to assess a group of deadly neurotoxins, thanks to University of Queensland-led research. Associate Professor Bryan Fry , of UQ's Venom Evolution Lab , said a new technique could replace conventional methods of testing paralytic neurotoxins, which previously required euthanasia of test subjects.

Health - Pharmacology - 28.10.2019
Health care prediction algorithm biased against black patients
From predicting who will be a repeat offender to who's the best candidate for a job, computer algorithms are now making complex decisions in lieu of humans. But increasingly, many of these algorithms are being found to replicate the same racial, socioeconomic or gender-based biases they were built to overcome.

This site uses cookies and analysis tools to improve the usability of the site. More information. |